Today: 11 June 2026
Seagate (STX) stock slips as 2025 AI-storage rally cools — what investors watch next
31 December 2025
2 mins read

Seagate (STX) stock slips as 2025 AI-storage rally cools — what investors watch next

NEW YORK, December 30, 2025, 22:25 ET — Market closed

  • Seagate shares closed down 0.4% Tuesday, extending a late-year pause after a sharp 2025 run-up
  • Storage peer Western Digital fell 2.0% as U.S. tech stocks drifted lower
  • Focus turns to Seagate’s late-January quarterly update and whether AI-led demand keeps lifting drive pricing

Seagate Technology Holdings plc shares fell 0.4% to close at $280.08 on Tuesday, after trading between $278.90 and $284.09.

The pullback matters because Seagate has been one of the market’s standout “AI infrastructure” winners this year, riding demand for data storage as cloud companies build out data centers. With the calendar turning, investors are reassessing how much of that story is already in the stock.

That debate has sharpened into year-end, when positioning can shift quickly and high-flying names often see profit-taking. Traders are also looking ahead to the company’s next quarterly results for clearer signals on pricing and shipments.

Tuesday’s move came alongside a modest decline in big-cap tech, with the Invesco QQQ Trust (QQQ) down 0.2% and the Technology Select Sector SPDR Fund (XLK) off 0.3%. Western Digital dropped 2.0% and Micron Technology eased 0.6%.

A Barron’s report on Monday flagged Seagate and Western Digital as surprise AI winners in 2025, driven by demand for high-capacity hard drives used in AI data centers. Seagate CEO Dave Mosley told Barron’s: “AI is fundamentally reshaping hard drive demand.” Barron’s

Seagate makes hard disk drives, or HDDs — spinning-disk devices that store data magnetically — and also sells other storage products, according to a Reuters company profile.

The company’s recent rally has also leaned on expectations that new manufacturing and recording technologies can raise capacities and margins. In its last quarterly update, Seagate said it was ramping shipments of its HAMR-based Mozaic drives — HAMR is heat-assisted magnetic recording, a method that uses heat to pack more data onto a disk — and it said those products were qualified with five of the world’s largest cloud customers.

That October report included guidance for fiscal second-quarter 2026 revenue of $2.70 billion, plus or minus $100 million, and non-GAAP (adjusted) earnings of $2.75 per share, plus or minus $0.20.

Analysts remain broadly positive, but the bar is higher after the stock’s run. MarketBeat data showed an average analyst price target of about $293.

Before the next session, traders will be watching whether storage names keep moving with the wider AI hardware trade or start to decouple on stock-specific positioning into year-end. Any fresh analyst notes on cloud spending or drive supply trends could also steer the group.

Looking beyond the holiday week, the next clear catalyst is Seagate’s quarterly results. Nasdaq’s earnings calendar lists an estimated report date of Jan. 20, though the company has not confirmed it.

On charts, Seagate is still sitting below its recent peak: MarketWatch data showed a 52-week high of $308.93 earlier this month, leaving the stock roughly 9% below that level at Tuesday’s close — a reference point traders often treat as near-term resistance.

Stock Market Today

  • Ideaya Biosciences Stock Drops 10% Amid $300M Fundraising Despite Bullish Outlook
    June 10, 2026, 10:30 PM EDT. Shares of Ideaya Biosciences ($IDYA) fell 10% to around $27 following the announcement of a $300 million stock offering priced at $27 per share, diluting existing shareholder value. The biotech firm had surged 13% earlier due to promising oncology trial results presented at ASCO. Analysts from Citizens reaffirmed a Market Outperform rating and a $45 target, citing robust pipeline developments and collaborations, including a deal with Roche on a novel oncology drug combination. Positive clinical data showed a 37% response rate in uveal melanoma, substantially outperforming standard care. The cash raise aims to advance multiple cancer trials, ensuring a solid financial runway despite near-term stock pressure from dilution.

Latest articles

Tech stocks slide after hours, Oracle’s AI spending draws focus

Tech stocks slide after hours, Oracle’s AI spending draws focus

11 June 2026
Semiconductor stocks plunged 3.6%, dragging the S&P 500 technology sector into correction territory—down 11% from its June 2 record—as investors punished AI-linked companies like Oracle and Super Micro Computer for heavy spending and capital raises, signaling a shift in risk appetite amid rising inflation and escalating U.S.-Iran tensions.
Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

Murphy USA Shares Spike 10% After Casey’s Margin Surge Rattles Gas Station Sector

11 June 2026
Murphy USA soared 10.04% to $612.16 as investors seized on Casey’s General Stores’ stronger-than-expected fuel margins, spotlighting sector-wide pump profitability; with Murphy’s own first-quarter fuel contribution up 40.6% and margins at 35.0 cents per gallon, the stock’s jump reflects bets that high margins will persist, though volatility in fuel prices remains a key risk.
Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

Sky Quarry Jumps in After-Hours; Traders Eye June Refinery Restart

11 June 2026
Sky Quarry soared 22.44% to $1.91 on record volume, then jumped to $2.38 after hours, as investors bet on a June refinery restart after repairs and a feedstock shortage crushed Q1 revenue to $383; with just $66,828 in cash and “substantial doubt” about its ability to continue, the stock’s fate hinges on hitting its June production target.
Rivian stock drops 5% after CEO share-sale filing as year-end trading thins
Previous Story

Rivian stock drops 5% after CEO share-sale filing as year-end trading thins

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop